Abdullah Gandomkar1, Hossein Poustchi2, Maryam Moini3, Mohsen Moghadami1, Hadi Imanieh1, Mohammad Reza Fattahi3, Seyyed Mohammad Taghi Ayatollahi4, Mohammad Mahdi Sagheb5, Amir Anushiravani6, Roozbeh Mortazavi6, Sadaf Ghajarieh Sepanlou7, Reza Malekzadeh8,9. 1. Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Liver, Pancreatic, and Biliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 3. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 4. Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. 5. Nephrology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 6. Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. 7. Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 8. Non-Communicable Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. malek@ams.ac.ir. 9. Tehran University of Medical Sciences, Tehran, Iran. malek@ams.ac.ir.
Abstract
OBJECTIVES: The pars cohort study (PCS) is a 10-year cohort study aiming to investigate the burden and the major risk factors of non-communicable diseases, and to establish a setting to launch interventions for prevention of these diseases and controlling their risk factors. METHODS: All inhabitants of Valashahr district in South of Iran, aged 40-75 years, were invited to undergo interviews and physical examination, and to provide biological samples. A total of 9264 invitees accepted to participate in the study (95 % participation rate) and were recruited from 2012 to 2014. Active follow-up was also carried out after 12 months. RESULTS: About 46 % of participants were male and 54 % were female. About 14.0 % of the participants were current smokers and 8.4 % were ever opium users. The prevalence of overweight and obesity were 37.3 and 18.2 %, respectively. The prevalence of hypertension was 26.9 %. A total of 49 participants died during a median follow-up of one year. CONCLUSIONS: PCS with its large scale and wealth of socio-economic and medical data can be a unique platform for studying the etiology of non-communicable diseases and effective interventions in Iran.
OBJECTIVES: The pars cohort study (PCS) is a 10-year cohort study aiming to investigate the burden and the major risk factors of non-communicable diseases, and to establish a setting to launch interventions for prevention of these diseases and controlling their risk factors. METHODS: All inhabitants of Valashahr district in South of Iran, aged 40-75 years, were invited to undergo interviews and physical examination, and to provide biological samples. A total of 9264 invitees accepted to participate in the study (95 % participation rate) and were recruited from 2012 to 2014. Active follow-up was also carried out after 12 months. RESULTS: About 46 % of participants were male and 54 % were female. About 14.0 % of the participants were current smokers and 8.4 % were ever opium users. The prevalence of overweight and obesity were 37.3 and 18.2 %, respectively. The prevalence of hypertension was 26.9 %. A total of 49 participants died during a median follow-up of one year. CONCLUSIONS: PCS with its large scale and wealth of socio-economic and medical data can be a unique platform for studying the etiology of non-communicable diseases and effective interventions in Iran.
Authors: Akram Pourshams; Hooman Khademi; Akbar Fazeltabar Malekshah; Farhad Islami; Mehdi Nouraei; Ali Reza Sadjadi; Elham Jafari; Nasser Rakhshani; Rasool Salahi; Shahryar Semnani; Farin Kamangar; Christian C Abnet; Bruce Ponder; Nick Day; Sanford M Dawsey; Paolo Boffetta; Reza Malekzadeh Journal: Int J Epidemiol Date: 2009-03-30 Impact factor: 7.196
Authors: F Malekzadeh; T Marshall; A Pourshams; M Gharravi; A Aslani; A Nateghi; M Rastegarpanah; M Khoshnia; S Semnani; R Salahi; G N Thomas; B Larijani; K K Cheng; R Malekzadeh Journal: Int J Clin Pract Date: 2010-08 Impact factor: 2.503
Authors: Arash Etemadi; Christian C Abnet; Farin Kamangar; Farhad Islami; Hooman Khademi; Akram Pourshams; Hossein Poustchi; Mohammad Bagheri; Amir Ali Sohrabpour; Ali Aliasgar; Masoud Khoshnia; Sholom Wacholder; Charles C Matthews; Paul D Pharoah; Paul Brennan; Paolo Boffetta; Reza Malekzadeh; Sanford M Dawsey Journal: Eur J Epidemiol Date: 2014-02-21 Impact factor: 8.082
Authors: Neda Zamani; Majid Hajifaraji; Akbar Fazel-tabar Malekshah; Abbas Ali Keshtkar; Ahmad Esmaillzadeh; Reza Malekzadeh Journal: Arch Iran Med Date: 2013-06 Impact factor: 1.354
Authors: Asieh Golozar; Hooman Khademi; Farin Kamangar; Hossein Poutschi; Farhad Islami; Christian C Abnet; Neal D Freedman; Philip R Taylor; Paul Pharoah; Paolo Boffetta; Paul J Brennan; Sanford M Dawsey; Reza Malekzadeh; Arash Etemadi Journal: PLoS One Date: 2011-10-28 Impact factor: 3.240
Authors: Arash Etemadi; Abdullah Gandomkar; Neal D Freedman; Mohsen Moghadami; Mohammad Reza Fattahi; Hossein Poustchi; Farhad Islami; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh Journal: Int J Epidemiol Date: 2017-12-01 Impact factor: 7.196